Human study · Aging · 19 Oct 2026
Longitudinal immune trajectories following SARS-CoV-2 vaccination in long-term care facility residents: an unsupervised analysis approach
Source: Frontiers in Aging
What the research found
BackgroundResidents of Long-Term Care Facilities (LTCFs) represent a highly vulnerable population characterized by immunosenescence, multimorbidity, and heterogeneous immune responses to repeated SARS-CoV-2 vaccination and infection. Conventional analyses based on single clinical variables often fail to capture this complexity. We evaluated longitudinal humoral immune responses in institutionalized older adults to id
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More aging news
- In middle-aged male mice, an earlier loss of new tumor-fighting immune cells lined up with weaker melanoma control
- A commentary says telomere RNA loops can stall DNA copying and, in some tumors, get used to keep chromosome ends going
- After a long decline, heart-valve death rates in U.S. older adults rose from 2018 to 2023
- In adults over 50 followed for 24 years, a higher body mass index lined up with a faster drop in memory and thinking
- A lab force on bone extended lifespan in older mice through a signal called PEDF